Literature DB >> 12032700

Targeting of cell receptors and gene transfer efficiency: a balancing act.

I Fajac1, S Grosse, P Briand, M Monsigny.   

Abstract

Vectors conjugated with ligands recognized by cell surface receptors are of interest for cystic fibrosis gene therapy since these vectors would allow cell-specific targeting. However, an efficient and specific uptake may be abrogated by a subsequent intracellular trafficking leading to an inefficient gene transfer. This has been shown for polylysine substituted with mannose residues. While mannose-specific membrane lectins are predominantly expressed at the surface of airway cells and mannosylated complexes are the most efficiently incorporated glycosylated complexes in these cells, mannosylated complexes lead to a low gene transfer efficiency because of an inefficient exit from endosomal compartments, a high accumulation in lysosomes and an inefficient nuclear import. In contrast, the entry of low amounts of lactosylated complexes is balanced by more efficient intracellular trafficking, leading to an efficient gene transfer. This emphasizes that for a successful gene transfer, it is necessary to find the balance between efficient and specific uptake, and intracellular trafficking that overcomes the various cellular barriers and enables the plasmid to reach the nucleus.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12032700     DOI: 10.1038/sj.gt.3301738

Source DB:  PubMed          Journal:  Gene Ther        ISSN: 0969-7128            Impact factor:   5.250


  2 in total

Review 1.  Carrier-based strategies for targeting protein and peptide drugs to the lungs.

Authors:  Sally-Ann Cryan
Journal:  AAPS J       Date:  2005-03-24       Impact factor: 4.009

2.  Ion permeability of the nuclear pore complex and ion-induced macromolecular permeation as studied by scanning electrochemical and fluorescence microscopy.

Authors:  Jiyeon Kim; Anahita Izadyar; Mei Shen; Ryoichi Ishimatsu; Shigeru Amemiya
Journal:  Anal Chem       Date:  2014-02-06       Impact factor: 6.986

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.